BioAtla (BCAB) Short Interest Ratio & Short Volume $0.38 -0.01 (-2.40%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$0.37 -0.02 (-3.98%) As of 05/21/2025 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BioAtla Short Interest DataBioAtla (BCAB) has a short interest of 4.30 million shares. This marks a 5.91% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.9, indicating that it would take 5.9 days of the average trading volume of 952,096 shares to cover all short positions.Current Short Interest4,300,000 sharesPrevious Short Interest4,060,000 sharesChange Vs. Previous Month+5.91%Dollar Volume Sold Short$2.09 millionShort Interest Ratio5.9 Days to CoverLast Record DateApril 30, 2025Outstanding Shares58,418,000 sharesPercentage of Shares Shorted7.36%Today's Trading Volume435,734 sharesAverage Trading Volume952,096 sharesToday's Volume Vs. Average46% Short Selling BioAtla? Sign up to receive the latest short interest report for BioAtla and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBCAB Short Interest Over TimeBCAB Days to Cover Over TimeBCAB Percentage of Float Shorted Over Time BioAtla Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20254,300,000 shares $2.09 million +5.9%N/A5.9 $0.49 4/15/20254,060,000 shares $1.29 million -6.2%9.5%5.7 $0.32 3/31/20254,330,000 shares $1.50 million +2.6%10.1%5.2 $0.35 3/15/20254,220,000 shares $1.45 million +32.7%9.9%4 $0.34 2/28/20253,180,000 shares $1.04 million -17.0%7.4%2.9 $0.33 2/15/20253,830,000 shares $1.78 million -12.6%9.0%3.7 $0.46 1/31/20254,380,000 shares $2.06 million -13.4%N/A3.9 $0.47 1/15/20255,060,000 shares $2.44 million +15.0%N/A4.6 $0.48 12/31/20244,400,000 shares $2.60 million +11.4%N/A3.9 $0.59 12/15/20243,950,000 shares $5.73 million -0.8%N/A3 $1.45 Get the Latest News and Ratings for BCAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioAtla and its competitors with MarketBeat's FREE daily newsletter. 11/30/20243,980,000 shares $6.69 million -3.9%N/A3.4 $1.68 11/15/20244,140,000 shares $6.46 million -15.0%N/A3.5 $1.56 10/31/20244,870,000 shares $9.35 million -7.1%N/A4 $1.92 10/15/20245,240,000 shares $10.22 million +17.2%N/A4.4 $1.95 9/30/20244,470,000 shares $7.87 million +0.5%N/A3.8 $1.76 9/15/20244,450,000 shares $8.05 million No ChangeN/A4.9 $1.81 8/31/20244,450,000 shares $7.88 million -6.3%N/A5 $1.77 8/15/20244,750,000 shares $8.93 million +18.8%N/A5 $1.88 7/31/20244,000,000 shares $7.24 million +0.5%N/A4.7 $1.81 7/15/20243,980,000 shares $6.97 million -24.2%N/A4.5 $1.75 6/30/20245,250,000 shares $7.19 million -3.3%N/A6.4 $1.37 6/15/20245,430,000 shares $8.63 million +0.6%N/A7 $1.59 5/31/20245,400,000 shares $8.15 million +3.9%N/A7.1 $1.51 5/15/20245,200,000 shares $15.60 million -2.4%N/A7.4 $3.00 4/30/20245,330,000 shares $12.02 million -1.7%N/A8.8 $2.26 4/15/20245,420,000 shares $15.50 million -3.0%N/A10.1 $2.86 3/31/20245,590,000 shares $19.23 million +9.0%N/A10.9 $3.44 3/15/20245,130,000 shares $12.52 million +0.4%N/A11.6 $2.44 2/29/20245,110,000 shares $13.80 million +1.4%N/A11 $2.70 2/15/20245,040,000 shares $13.36 million +6.6%N/A9.6 $2.65 1/31/20244,730,000 shares $9.06 million -3.3%N/A9.5 $1.92 1/15/20244,890,000 shares $11.78 million +4.7%N/A9.5 $2.41 12/31/20234,670,000 shares $11.49 million +4.7%N/A9.5 $2.46 12/15/20234,460,000 shares $9.41 million +0.2%N/A9.6 $2.11 11/30/20234,450,000 shares $7.88 million +8.0%N/A10.9 $1.77 11/15/20234,120,000 shares $6.63 million +1.0%N/A12.1 $1.61 10/31/20234,080,000 shares $6.00 million -7.3%N/A13.9 $1.47 10/15/20234,400,000 shares $7.26 million -5.2%N/A17.5 $1.65 9/30/20234,640,000 shares $7.89 million -6.8%N/A20.1 $1.70 9/15/20234,980,000 shares $10.36 million +2.1%N/A20.7 $2.08Trump Exec Order 14179 is wealth “gift” to good Americans? (Ad)Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.If you missed out on a bitcoin fortune, this could be your second chance. A brief “wealth window” is 8/31/20234,880,000 shares $12.25 million +3.2%N/A13.6 $2.51 8/15/20234,730,000 shares $12.91 million +1.9%N/A12.1 $2.73 7/31/20234,640,000 shares $13.87 million -1.1%N/A11.1 $2.99 7/15/20234,690,000 shares $12.66 million +1.5%N/A10.7 $2.70 6/30/20234,620,000 shares $13.86 million +25.9%N/A8.7 $3.00 6/15/20233,670,000 shares $13.73 million +1.7%N/A6.1 $3.74 5/31/20233,610,000 shares $11.37 million +0.6%N/A7.3 $3.15 5/15/20233,590,000 shares $13.89 million -5.0%N/A7.2 $3.87 4/30/20233,780,000 shares $12.74 million +16.7%N/A7.4 $3.37 4/15/20233,240,000 shares $11.66 million -10.3%N/A5.7 $3.60 3/31/20233,610,000 shares $9.67 million +10.4%N/A4.5 $2.68 3/15/20233,270,000 shares $8.37 million -0.6%N/A4.6 $2.56 2/28/20233,290,000 shares $9.80 million +13.8%N/A4.8 $2.98 2/15/20232,890,000 shares $9.88 million -0.3%N/A4.3 $3.42 1/31/20232,900,000 shares $10.99 million -10.8%N/A3.3 $3.79 1/15/20233,250,000 shares $11.25 million -21.9%N/A3.7 $3.46 12/30/20224,160,000 shares $34.32 million +2.2%N/A6.4 $8.25 12/15/20224,070,000 shares $36.51 million -5.1%N/A7.5 $8.97 11/30/20224,290,000 shares $47.23 million -3.6%N/A7.7 $11.01 11/15/20224,450,000 shares $39.16 million +10.2%N/A8 $8.80 10/31/20224,040,000 shares $27.84 million -20.6%N/A3.5 $6.89 10/15/20225,090,000 shares $35.07 million -1.0%N/A5.4 $6.89 9/30/20225,140,000 shares $39.58 million +27.5%N/A5.2 $7.70 9/15/20224,030,000 shares $34.46 million +7.8%N/A3.7 $8.55 8/31/20223,740,000 shares $32.58 million -32.9%N/A3.6 $8.71 8/15/20225,570,000 shares $44.56 million +27.2%N/A5.2 $8.00 7/31/20224,380,000 shares $14.89 million -9.5%N/A7.7 $3.40 7/15/20224,840,000 shares $20.38 million +19.5%N/A7.9 $4.21 6/30/20224,050,000 shares $11.54 million +2.3%N/A6.5 $2.85 6/15/20223,960,000 shares $10.49 million -1.5%N/A5.8 $2.65 5/31/20224,020,000 shares $9.69 million +2.6%N/A5.5 $2.41 5/15/20223,920,000 shares $9.02 million +1.8%N/A5.3 $2.30 4/30/20223,850,000 shares $13.40 million +5.8%N/A5.2 $3.48 4/15/20223,640,000 shares $14.56 million +1.7%N/A5.1 $4.00 3/31/20223,580,000 shares $17.90 million -5.0%N/A5 $5.00 3/15/20223,770,000 shares $18.93 million -4.8%N/A6.2 $5.02 2/28/20223,960,000 shares $25.66 million -6.2%N/A7.8 $6.48 2/15/20224,220,000 shares $29.58 million +6.6%N/A8.8 $7.01 1/31/20223,960,000 shares $37.86 million +12.8%N/A9.6 $9.56 1/15/20223,510,000 shares $44.33 million +9.0%N/A10.5 $12.63 12/31/20213,220,000 shares $63.21 million +4.2%N/A12.7 $19.63 12/15/20213,090,000 shares $65.11 million +16.2%N/A15.1 $21.07 11/30/20212,660,000 shares $67.17 million +10.4%N/A11.7 $25.25 11/15/20212,410,000 shares $65.50 million -13.9%N/A10.8 $27.18 10/29/20212,800,000 shares $81.84 million No ChangeN/A12.5 $29.23 10/15/20212,800,000 shares $79.38 million -3.5%N/A11.9 $28.35 9/30/20212,900,000 shares $85.38 million +7.0%N/A12.4 $29.44 9/15/20212,710,000 shares $99.89 million -6.6%N/A11.3 $36.86 8/31/20212,900,000 shares $119.16 million -2.4%N/A11.3 $41.09 8/13/20212,970,000 shares $122.39 million -7.5%N/A13.6 $41.21Trump Exec Order 14179 is wealth “gift” to good Americans? (Ad)Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.If you missed out on a bitcoin fortune, this could be your second chance. A brief “wealth window” is 7/30/20213,210,000 shares $131.58 million -3.3%N/A15.4 $40.99 7/15/20213,320,000 shares $125.46 million +0.6%N/A17 $37.79 6/30/20213,300,000 shares $139.85 million +11.1%N/A16.6 $42.38 6/15/20212,970,000 shares $117.73 million +8.8%N/A15.8 $39.64 5/28/20212,730,000 shares $117.53 million +1.5%N/A14.1 $43.05 5/14/20212,690,000 shares $122.61 million +13.5%12.8%11.4 $45.58 4/30/20212,370,000 shares $121.37 million +2.2%11.2%9.4 $51.21 4/15/20212,320,000 shares $106.81 million +11.5%12.9%8.8 $46.04 3/31/20212,080,000 shares $104.73 million +54.1%11.5%7.4 $50.35 3/15/20211,350,000 shares $89.65 million +63.6%7.5%4.6 $66.41 2/26/2021825,000 shares $44.57 million +28.2%4.6%2.5 $54.03 2/12/2021643,700 shares $34.24 million +641.6%3.6%2 $53.19 1/29/202186,800 shares $3.77 million +76.4%0.5%0.2 $43.47 1/15/202149,200 shares $2.29 million No Change0.3%0.1 $46.52 BCAB Short Interest - Frequently Asked Questions What is BioAtla's current short interest? Short interest is the volume of BioAtla shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 4,300,000 shares of BCAB short. Learn More on BioAtla's current short interest. What is a good short interest ratio for BioAtla? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCAB shares currently have a short interest ratio of 6.0. Learn More on BioAtla's short interest ratio. Is BioAtla's short interest increasing or decreasing? BioAtla saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 4,300,000 shares, an increase of 5.9% from the previous total of 4,060,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BioAtla's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BioAtla: Invivyd, Inc. (9.93%), MacroGenics, Inc. (9.79%), Black Diamond Therapeutics, Inc. (16.60%), Contineum Therapeutics, Inc. (4.28%), Entera Bio Ltd. (0.31%), Kyverna Therapeutics, Inc. (10.90%), OptiNose, Inc. (1.68%), HilleVax, Inc. (8.13%), Immunic, Inc. (2.86%), Cardiol Therapeutics Inc. (2.57%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short BioAtla stock? Short selling BCAB is an investing strategy that aims to generate trading profit from BioAtla as its price is falling. BCAB shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioAtla? A short squeeze for BioAtla occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BCAB, which in turn drives the price of the stock up even further. How often is BioAtla's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCAB, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Invivyd Short Interest MacroGenics Short Interest Black Diamond Therapeutics Short Interest Contineum Therapeutics Short Interest Entera Bio Short Interest Kyverna Therapeutics Short Interest OptiNose Short Interest HilleVax Short Interest Immunic Short Interest Cardiol Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCAB) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioAtla, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioAtla With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BCAB Stock Free BCAB Stock Alerts